The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease
A key criterion for the most common chronic liver disease—non-alcoholic fatty liver disease (NAFLD)—is an intrahepatic fat content above 5% in individuals who are not using steatogenic agents or having significant alcohol intake. Subjects with NAFLD have increased plasma concentrations of glucagon,...
Main Author: | Katrine D. Galsgaard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/4049 |
Similar Items
-
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis
by: Marie Winther-Sørensen, et al.
Published: (2020-12-01) -
Glucagon Receptor Signaling and Lipid Metabolism
by: Katrine D. Galsgaard, et al.
Published: (2019-04-01) -
Postprandial dysfunction in fatty liver disease
by: Josephine Grandt, et al.
Published: (2023-04-01) -
Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
by: Salvatore Pezzino, et al.
Published: (2022-11-01) -
The relationship between glucose and the liver-alpha cell axis – A systematic review
by: Thomas Pixner, et al.
Published: (2023-01-01)